Stroke research studies
We are recruiting for two studies within stroke:
The overall aim of our research is to find out whether fluoxetine improves recovery if given to stroke survivors who are between 2 and 15 days after the onset of their stroke, and who still have residual problems such as a weak arm, weak leg or language problems. We will also find out whether it helps the stroke survivor overcome weakness, communication difficulties or fatigue. We will do this by performing a large randomised trial in the UK, recruiting approximately 3000 patients. Half the patients will be randomly allocated fluoxetine for 6 months, and the other half will receive a placebo pill. For patients who cannot swallow, we will give the drug or a matching placebo through their feeding tube. Patients will be followed up at 6 months, and then at 12 months, to see whether any benefits persist long-term.